Medical Oncology

Papers
(The TQCC of Medical Oncology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Oncotype DX testing does not affect clinical practice in stage IIa colon cancer52
The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer30
COVID-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients27
The immunomodulatory effects of Candida albicans isolated from the normal gastrointestinal microbiome of the elderly on colorectal cancer26
How to ensure uninterrupted treatment of radiotherapy patients during delta variants of SARS-CoV-2 virus epidemic: the latest experience from Xi’an, China22
The role of inflammatory indices in the outcome of COVID-19 cancer patients22
Enhancement of Apo2L/TRAIL signaling pathway receptors by the activation of Klotho gene with CRISPR/Cas9 in Caco-2 colon cancer cells20
Regulatory mechanisms of heme regulatory protein BACH1: a potential therapeutic target for cancer19
DNMT1 and miRNAs: possible epigenetics footprints in electromagnetic fields utilization in oncology19
The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer18
The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 si17
Notch signaling in oral pre-cancer and oral cancer16
Innovation in cancer therapeutics and regulatory perspectives16
Mefenamic acid as a promising therapeutic medicine against colon cancer in tumor-bearing mice15
A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways14
sABLATE: a simplified ABLATE score for prediction of complications and outcome in percutaneous thermal ablation of renal lesions14
Interferon regulatory factor-1 regulates cisplatin-induced apoptosis and autophagy in A549 lung cancer cells14
Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model14
Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies14
AFP peptide (AFPep) as a potential growth factor for prostate cancer14
Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells13
In silico bioinformatics analysis for identification of differentially expressed genes and therapeutic drug molecules in Glucocorticoid-resistant Multiple myeloma13
Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial–mesenchymal transition in prostate cancer13
Direct oral anticoagulants in cancer patients: which help from the specialist hemostasis and thrombosis laboratory?13
AICAR enhances the cytotoxicity of PFKFB3 inhibitor in an AMPK signaling-independent manner in colorectal cancer cells13
DNA methylation marker to estimate ovarian cancer cell fraction13
0.14515995979309